07.10.21 -- The Right Payment System Makes Bayer Healthcare A Sponsor Of Choice

COVID-19 has had a dramatic impact on U.S. clinical care, including how sites have worked to maintain research operations throughout the pandemic. The financial and logistical challenges faced by our site partners have been substantial; here is a recap of the adaptations they’ve made to manage through the current environment.

A technology or solution created with thoughtful, strategic design will elevate the experience of the user. By applying the strength and worldwide reputation of IBM design to clinical trial technology, the company is set to revolutionize — and significantly improve — the experiences of both patients and site personnel.

Trial master file (TMF) quality control is a topic that always seems to be present on conference agendas, and it invokes much discussion and debate. Many clinical trial sponsors and contract research organizations (CROs) are struggling to understand what is needed in terms of quality control and quality review activities and how these can be done more efficiently to improve TMF health and inspection-readiness. This blog explains how to best meet the requirements for effective quality control in a trial master file.

In this Q&A we dig into some of the essential elements our experts identify as key to maintaining and enhancing both existing and new partnerships. Learn how outsourcing this key aspect of bringing a product to market can benefit your organization and overall supply chain optimization.

If you want to meet patients where they are and make data available to CROs and sponsors in real time, eliminating the majority of source data verification (SDV) is key. With evolving infectious disease situations, near-immediate access enables teams to respond to individual or epidemiologic developments right away. Learn about a leading pharma company’s Phase 3 trial for a COVID-19 prophylactic therapy in 1,000+ patients at 82 sites.

Clinical researchers are looking for ways to reduce the operational challenges of clinical trials, which can often occur by working with multiple sponsors. Some of these challenges include working with individual sponsor portals, using disparate processes and numerous platforms — each with a unique login credential — all of which can lead to increased probability for error and placing patient safety in jeopardy. A cancer center turned to a shared investigator platform (SIP) integration to streamline the interaction with multiple sponsors.

This e-book examines the impact of specialty products and the packaging challenges associated with them, addressing the benefits of small-volume commercial packaging and supply chain partner selection.

Clinical trials are getting increasingly complex, challenging their very planning and execution. To meet these challenges, AI-enabled technologies and advanced analytics become a true necessity. In this e-book, explore intelligent trials use cases for enterprise sponsors, midsize/emerging sponsors, and CROs. Whether you’re managing a portfolio or looking to ensure the success of a single trial, our unique data, advanced analytics, and resulting insights can help every trial achieve its full potential.

Chief pathologist John Cochran discusses how clinical trials offer pathologists the opportunity to work at the forefront of diagnostic discovery.

Ransomware is a relatively new tool in the cybercriminal’s arsenal for extorting money from businesses. It is a low-effort/high-reward activity that will cost businesses $6 trillion annually. In the fast-moving, data-intensive life sciences industry, ransomware attacks are particularly nasty. When the hopes of an entire economy rely on the rapid development of a vaccine, or lives hang on getting a breakthrough treatment to market, downtime is not an option. Here are the facts.

Direct-to-patient (DTP) distribution of clinical supplies provides trial sponsors with the opportunity to support improved recruitment and retention rates for their studies by removing or reducing the travel and time commitments that can otherwise inhibit patients’ willingness and ability to participate. Watch the webinar to learn about the results from a recent industry survey that sought to gain insight on trial sponsors’ perspectives on offering a DTP option and their current level of awareness and understanding of any factors that may influence their ability to do so.

The increasing complexity and spiraling costs of running clinical trials have forced life sciences organizations to renew their focus on improving operational efficiencies, particularly as the industry moves to embrace personalized medicine, with its lower per-patient revenue model. There’s no silver bullet, of course. But innovative machine learning techniques show great promise in helping life sciences companies identify and rectify systemic inefficiencies, allowing them to learn and adapt.

In this webinar we will be exploring how to manage a supply chain through interactive response technology (IRT) with self-service tools and actionable insights as well as best practices for supply forecasting and overstock management.